
Michael T Yin
Infectious Disease · Trustees of Columbia University in the City of New York
Credentials: · ·
History
NewYork-Presbyterian Hospital/Columbia University Medical Center
NewYork-Presbyterian Hospital/Columbia University Medical Center

Research
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Nature · 2021 · 1,817 citations
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Nature · 2020 · 1,218 citations
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Nature · 2022 · 1,088 citations

33 papers

33 papers

27 papers

26 papers

23 papers
- ES
18 papers

18 papers

17 papers
Grants
- 2026–2031
Columbia University-Weill Cornell Medicine CFAR (CU-WCM CFAR)
National Institute of Allergy and Infectious Diseases · P30
Project lead · $473.8K · Columbia University Health Sciences
- 2021–2028
Effectiveness of Comprehensive ETE Interventions in the Dental Setting
National Institute of Dental and Craniofacial Research · UH3
Contact PI · $3.6M · Columbia University Health Sciences
- 2023–2028
Hormone Therapy for Peri- and Postmenopausal Women with HIV (HoT)
National Institute on Aging · R01
Contact PI · $2.7M · Columbia University Health Sciences
- 2023–2028
Quick and Accurate Measurements of HIV Broadly Neutralizing Antibody Susceptibility
National Institute of Allergy and Infectious Diseases · R33
PI · $1M · Columbia University Health Sciences
Clinical trials
- 2024–2025
- 2022–2024
- 2021–2022
- 2009–2017
Study chair · Terminated · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
